Skip to content
WellForm MD

Free GLP-1 tool

GLP-1 Dosing Calendar Generator

Organize injection dates. The calendar never decides that you are ready to increase.

Calendar type

The calendar distinguishes a label reference from a clinician-directed schedule. Reminder dates stay at the dose you entered. A date never authorizes an increase.

What this result means

Build a weekly calendar from the labeled reference schedule or stay on the clinician-directed dose.

Reminder dates stay at the clinician-directed dose you enter. Label reference lists minimum intervals and labeled options only. The calendar never assigns a future increase because a date arrived.

What this tool cannot tell you

  • That you are ready to move to a higher dose.
  • What to do after a missed dose — use the missed-dose planner.
  • Whether a labeled step matches your prescription.

Methodology & sources

Reminder dates stay at the clinician-directed dose you enter. Label reference lists minimum intervals and labeled options only. The calendar never assigns a future increase because a date arrived.

  • WEGOVY (semaglutide) injection / tablet prescribing information

    U.S. National Library of Medicine DailyMed / Novo Nordisk · 2026-06 · Last verified 2026-09-16

    Used for Wegovy injection missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 to 7 weeks after the last 2.4 mg or 7.2 mg injection). Tablet rules are not encoded.

  • OZEMPIC (semaglutide) injection prescribing information

    U.S. National Library of Medicine DailyMed / Novo Nordisk · Last verified 2026-09-16

    Used for Ozempic missed-dose, labeled weekly schedule, pen/syringe storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 weeks after the last dose; steady state after 4 to 5 weekly doses).

  • ZEPBOUND (tirzepatide) injection prescribing information

    U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16

    Used for Zepbound missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-to-6-day half-life; steady state after 4 weekly doses).

  • MOUNJARO (tirzepatide) injection prescribing information

    U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16

    Used for Mounjaro missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-day half-life; steady state after 4 weekly doses).

Related WellForm MD resources

Need individualized guidance?

These tools are free public education. WellForm MD also provides physician-led medical weight-loss care when you want a plan that belongs to you.

Book a free consultation